CorMedix Inc expected to post a loss of 10 cents a share - Earnings Preview

CorMedix

28/10/2024 13:02

* CorMedix Inc  CRMD.OQ   CRMD.O  is expected to show a rise
in
quarterly revenue when it reports  results on October 30 for the
period ending September 30 2024
    * The Berkeley Heights New Jersey-based  company is expected
to
report revenue of $10.839 million, according to the mean
estimate from 4 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for CorMedix Inc is for a
loss
of 10 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CorMedix
Inc is
13.50​, above​ its last closing price of $13.04. ​​​

This summary was machine generated October 28 at 13:01 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)